Jury Still Out on Neural Tube Defects From Dolutegravir Jury Still Out on Neural Tube Defects From Dolutegravir

After an increased risk for neural tube defects emerged in women taking dolutegravir at conception in a Botswanan cohort, researchers around the world began reviewing their data for any such signal.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: HIV/AIDS News Source Type: news